Admelog

Product manufactured by Sanofi-Aventis U.s. Llc

Application Nr Approved Date Route Status External Links
BLA209196 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Admelog Is Indicated To Improve Glycemic Control In Adults And Pediatric Patients 3 Years And Older With Type 1 Diabetes Mellitus And Adults With Type 2 Diabetes Mellitus. Admelog Is A Rapid-Acting Human Insulin Analog Indicated To Improve Glycemic Control In Adults And Pediatric Patients 3 Years And Older With Type 1 Diabetes Mellitus And Adults With Type 2 Diabetes Mellitus. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Insulin Lispro

Comments